DESIGN PHARMACEUTICALS Trademark

Trademark Overview


On Tuesday, May 5, 2020, a trademark application was filed for DESIGN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the DESIGN PHARMACEUTICALS trademark a serial number of 88901981. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 19, 2021. This trademark is owned by Design Pharmaceuticals Inc.. The DESIGN PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; consulting services in the field research and development, namely, research and development of pharmaceutical therapeutics; consultancy relating to research and development in the field of therape...
design pharmaceuticals

General Information


Serial Number88901981
Word MarkDESIGN PHARMACEUTICALS
Filing DateTuesday, May 5, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 19, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; consulting services in the field research and development, namely, research and development of pharmaceutical therapeutics; consultancy relating to research and development in the field of therapeutics; pharmaceutical research services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 17, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDesign Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Thursday, January 21, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 19, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020ASSIGNED TO EXAMINER
Sunday, May 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 8, 2020NEW APPLICATION ENTERED IN TRAM